Brief: Nih Says Monkeypox Treatment Trial Begins In The Democratic Republic Of The Congo
12/10/2022 18:07
Oct 12 (Reuters) - NIH :
* NIH SAYS MONKEYPOX TREATMENT TRIAL BEGINS IN THE
DEMOCRATIC
REPUBLIC OF THE CONGO
* NIH SAYS IT IS PARTNERING WITH INRB TO EVALUATE
TECOVIRIMAT
(TPOXX)
Further company coverage: SIGA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on SIGA Technologies
See all newsBrief: Siga Secures Contract Valued At Up To $15 Million From Canadian Department Of National Defence To Purchase Tpoxx®
SIGA Technologies Q2 revenue, profit drop as contract ends
SIGA Technologies Q1 revenue falls, net loss widens
Brief: SIGA Technologies Q1 EPS USD -0.05
Brief: EMA Recommends Restricting Use Of Tecovirimat SIGA